GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Transcat Inc (NAS:TRNS) » Definitions » Intrinsic Value: Projected FCF
中文

Transcat (Transcat) Intrinsic Value: Projected FCF : $35.12 (As of Apr. 24, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Transcat Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-24), Transcat's Intrinsic Value: Projected FCF is $35.12. The stock price of Transcat is $111.27. Therefore, Transcat's Price-to-Intrinsic-Value-Projected-FCF of today is 3.2.

The historical rank and industry rank for Transcat's Intrinsic Value: Projected FCF or its related term are showing as below:

TRNS' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.86   Med: 1.74   Max: 4.81
Current: 3.17

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Transcat was 4.81. The lowest was 0.86. And the median was 1.74.

TRNS's Price-to-Projected-FCF is ranked worse than
94.21% of 121 companies
in the Industrial Distribution industry
Industry Median: 0.83 vs TRNS: 3.17

Transcat Intrinsic Value: Projected FCF Historical Data

The historical data trend for Transcat's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcat Intrinsic Value: Projected FCF Chart

Transcat Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.61 14.23 18.24 19.92 23.19

Transcat Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.08 23.19 25.22 29.79 35.12

Competitive Comparison of Transcat's Intrinsic Value: Projected FCF

For the Industrial Distribution subindustry, Transcat's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transcat's Price-to-Projected-FCF Distribution in the Industrial Distribution Industry

For the Industrial Distribution industry and Industrials sector, Transcat's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Transcat's Price-to-Projected-FCF falls into.



Transcat Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Transcat's Free Cash Flow(6 year avg) = $10.66.

Transcat's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec23)*0.8)/Shares Outstanding (Diluted Average)
=(12.437096484727*10.66224+218.47*0.8)/8.752
=35.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Transcat  (NAS:TRNS) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Transcat's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=111.27/35.121493101384
=3.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Transcat Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Transcat's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Transcat (Transcat) Business Description

Traded in Other Exchanges
N/A
Address
35 Vantage Point Drive, Rochester, NY, USA, 14624
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.
Executives
Lee D. Rudow officer: Chief Operating Officer C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
James M. Jenkins officer: Gen Counsel & VP of Corp Devt 1600 BAUSCH & LOMB PLACE, ROCHESTER NY 14604
Craig D. Cairns director C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Dawn Deperrior director 45 SOUTH MAIN STREET, FAIRPORT NY 14450
Christopher P. Gillette director C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Charles P Hadeed officer: VP-Finance and CFO 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Scott Deverell other: Principal Accounting Officer 100 CHESTNUT STREET, SUITE 600, ROCHESTER NY 14604
Richard J Harrison director 44 SOUTHERN PARKWAY, ROCHESTER NY 14618
Theresa A. Conroy officer: VP, Human Resources C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Cynthia Langston director C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Thomas L Barbato officer: Sr. VP Finance & CFO 105 NORTON STREET, NEWARK NY 14513
Carl E Sassano director, officer: Chairman, President and CEO C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Gary J. Haseley director C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Michael W. West officer: VP Distribution & Marketing C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Mbago M. Kaniki director C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624